Zacks: Brokerages Set $35.00 Price Target for TTEC Holdings Inc (NASDAQ:TTEC)

Share on StockTwits

TTEC Holdings Inc (NASDAQ:TTEC) has been given a consensus broker rating score of 3.00 (Hold) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation.

Brokers have set a 1 year consensus price objective of $35.00 for the company and are expecting that the company will post $0.11 earnings per share for the current quarter, according to Zacks. Zacks has also assigned TTEC an industry rank of 110 out of 256 based on the ratings given to its competitors.

Several analysts have recently weighed in on the company. TheStreet raised United States Lime & Minerals from a “c+” rating to a “b” rating in a report on Wednesday, March 20th. BidaskClub upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, July 4th. Craig Hallum set a $12.00 price target on Century Casinos and gave the company a “buy” rating in a research report on Monday, June 17th. Zacks Investment Research cut Haynes International from a “hold” rating to a “sell” rating in a research report on Wednesday, May 8th. Finally, ValuEngine upgraded Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st.

NASDAQ TTEC traded down $0.54 during trading on Monday, reaching $45.70. 1,823 shares of the company’s stock were exchanged, compared to its average volume of 79,546. The firm has a market cap of $2.14 billion, a PE ratio of 30.49, a P/E/G ratio of 3.44 and a beta of 0.70. The company has a debt-to-equity ratio of 0.98, a quick ratio of 1.71 and a current ratio of 1.71. The stock has a 50 day simple moving average of $42.65. TTEC has a 1 year low of $23.01 and a 1 year high of $47.46.

TTEC (NASDAQ:TTEC) last posted its earnings results on Tuesday, May 7th. The business services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.16. TTEC had a return on equity of 21.29% and a net margin of 3.29%. The business had revenue of $394.36 million during the quarter, compared to the consensus estimate of $382.90 million. As a group, research analysts anticipate that TTEC will post 1.68 earnings per share for the current fiscal year.

In other TTEC news, EVP Martin F. Deghetto sold 25,317 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $39.00, for a total transaction of $987,363.00. Following the transaction, the executive vice president now owns 98,598 shares in the company, valued at approximately $3,845,322. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gregory A. Conley sold 750 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $36.84, for a total value of $27,630.00. Following the transaction, the director now owns 9,536 shares in the company, valued at approximately $351,306.24. The disclosure for this sale can be found here. Insiders sold a total of 61,067 shares of company stock worth $2,379,993 in the last 90 days. 69.45% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Investors Research Corp acquired a new position in TTEC during the 1st quarter worth approximately $29,000. PNC Financial Services Group Inc. grew its holdings in shares of TTEC by 481.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,721 shares of the business services provider’s stock worth $50,000 after acquiring an additional 1,425 shares during the period. Municipal Employees Retirement System of Michigan acquired a new stake in shares of TTEC in the 4th quarter worth approximately $115,000. BNP Paribas Arbitrage SA grew its holdings in shares of TTEC by 513.7% in the 1st quarter. BNP Paribas Arbitrage SA now owns 3,216 shares of the business services provider’s stock worth $117,000 after acquiring an additional 2,692 shares during the period. Finally, Metropolitan Life Insurance Co. NY grew its holdings in shares of TTEC by 322.7% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 4,781 shares of the business services provider’s stock worth $137,000 after acquiring an additional 3,650 shares during the period. Institutional investors own 25.85% of the company’s stock.

About TTEC

TTEC Holdings, Inc designs and provides customer experience solutions in the United States, Latin America, Europe, the Middle East, Africa, the Asia Pacific, Canada, the United Kingdom, and internationally. It operates in four segments: Customer Management Services (CMS), Customer Growth Services (CGS), Customer Technology Services (CTS), and Customer Strategy Services (CSS).

Featured Story: Short Selling Stocks, A Beginner’s Guide

Get a free copy of the Zacks research report on TTEC (TTEC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for TTEC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TTEC and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases AvalonBay Communities  Price Target to $224.00
JPMorgan Chase & Co. Increases AvalonBay Communities Price Target to $224.00
Brightsphere Investment Group  Lifted to “Hold” at Zacks Investment Research
Brightsphere Investment Group Lifted to “Hold” at Zacks Investment Research
PLDT  Rating Lowered to Hold at Zacks Investment Research
PLDT Rating Lowered to Hold at Zacks Investment Research
AtriCure  Stock Rating Lowered by Northland Securities
AtriCure Stock Rating Lowered by Northland Securities
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine


 
© 2006-2019 Zolmax.